Does SOTROVIMAB Cause Interstitial lung disease? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Interstitial lung disease have been filed in association with SOTROVIMAB. This represents 0.2% of all adverse event reports for SOTROVIMAB.
6
Reports of Interstitial lung disease with SOTROVIMAB
0.2%
of all SOTROVIMAB reports
2
Deaths
4
Hospitalizations
How Dangerous Is Interstitial lung disease From SOTROVIMAB?
Of the 6 reports, 2 (33.3%) resulted in death, 4 (66.7%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SOTROVIMAB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does SOTROVIMAB Cause?
Exposure during pregnancy (1,348)
Infusion related reaction (275)
Product storage error (259)
Off label use (231)
Pyrexia (185)
Covid-19 (158)
Nausea (135)
Dyspnoea (134)
Live birth (133)
Pruritus (107)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which SOTROVIMAB Alternatives Have Lower Interstitial lung disease Risk?
SOTROVIMAB vs SOVALDI
SOTROVIMAB vs SOYBEAN OIL
SOTROVIMAB vs SPARSENTAN
SOTROVIMAB vs SPARTALIZUMAB
SOTROVIMAB vs SPESOLIMAB-SBZO